"Organs at Risk" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Organs which might be damaged during exposure to a toxin or to some form of therapy. It most frequently refers to healthy organs located in the radiation field during radiation therapy.
Concept/Terms
Organs at Risk- Organs at Risk
- Organs at Risks
- Risk, Organs at
- Risks, Organs at
- at Risk, Organs
- at Risks, Organs
Below are MeSH descriptors whose meaning is more general than "Organs at Risk".
Below are MeSH descriptors whose meaning is more specific than "Organs at Risk".
This graph shows the total number of publications written about "Organs at Risk" by people in Harvard Catalyst Profiles by year, and whether "Organs at Risk" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 4 | 6 | 10 |
| 2011 | 1 | 3 | 4 |
| 2012 | 9 | 6 | 15 |
| 2013 | 4 | 8 | 12 |
| 2014 | 3 | 9 | 12 |
| 2015 | 6 | 6 | 12 |
| 2016 | 6 | 11 | 17 |
| 2017 | 4 | 9 | 13 |
| 2018 | 9 | 8 | 17 |
| 2019 | 7 | 6 | 13 |
| 2020 | 3 | 8 | 11 |
| 2021 | 1 | 5 | 6 |
Below are the most recent publications written about "Organs at Risk" by people in Profiles.
-
Proton range uncertainty reduction benefits for skull base tumors in terms of normal tissue complication probability (NTCP) and healthy tissue doses. Med Phys. 2021 Sep; 48(9):5356-5366.
-
Target coverage and cardiopulmonary sparing with the updated ESTRO-ACROP contouring guidelines for postmastectomy radiation therapy after breast reconstruction: a treatment planning study using VMAT and proton PBS techniques. Acta Oncol. 2021 Nov; 60(11):1440-1451.
-
Proton vs. photon radiotherapy for MR-guided dose escalation of intraprostatic lesions. Acta Oncol. 2021 Oct; 60(10):1283-1290.
-
Anatomic changes in head and neck intensity-modulated proton therapy: Comparison between robust optimization and online adaptation. Radiother Oncol. 2021 06; 159:39-47.
-
A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity Modulated Radiation Therapy in Early-Stage Prostate Cancer Patients. Int J Radiat Oncol Biol Phys. 2021 07 15; 110(4):1082-1089.
-
The impact of variable relative biological effectiveness in proton therapy for left-sided breast cancer when estimating normal tissue complications in the heart and lung. Phys Med Biol. 2021 01 30; 66(3):035023.
-
Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy. Radiat Oncol. 2020 Sep 22; 15(1):221.
-
Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain. Int J Radiat Oncol Biol Phys. 2021 05 01; 110(1):68-86.
-
Proton monoenergetic arc therapy (PMAT) to enhance LETd within the target. Phys Med Biol. 2020 08 19; 65(16):165006.
-
ILROG Lymphoma Mini-Atlas Part II, Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys. 2020 11 15; 108(4):977-978.